These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10222655)

  • 1. Multiple myeloma preceding the development of chronic myelogenous leukemia.
    Nitta M; Tsuboi K; Yamashita S; Kato M; Hayami Y; Harada S; Komatsu H; Iida S; Banno S; Wakita A; Ueda R
    Int J Hematol; 1999 Apr; 69(3):170-3. PubMed ID: 10222655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma and chronic myelogenous leukemia--a case report with literature review.
    Klenn PJ; Hyun BH; Lee YH; Zheng WY
    Yonsei Med J; 1993 Sep; 34(3):293-300. PubMed ID: 8259707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
    Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
    Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
    Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential display analysis of mRNAs in chronic myelogenous leukaemia.
    el-Awady MK; Abdalla NM; Salem AM; Samir S; Nour AM
    East Mediterr Health J; 2001; 7(4-5):707-15. PubMed ID: 15332769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
    Luo Z; Chen H; Luo S; Tang L; Wang J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia, BCR-ABL1+.
    Vardiman JW
    Am J Clin Pathol; 2009 Aug; 132(2):250-60. PubMed ID: 19605820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological and molecular response evaluation of CML patients on imatinib.
    Gupta A; Prasad K
    J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
    Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
    Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
    Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
    Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma.
    Martiat P; Mecucci C; Nizet Y; Stul M; Philippe M; Cassiman JJ; Michaux JL; Van den Berghe H; Sokal G
    Leukemia; 1990 Nov; 4(11):751-4. PubMed ID: 2232886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
    Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
    Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.